Author:
Amini-Rarani Mostafa,Moeeni Maryam,Ponnet Koen
Abstract
Abstract
Background
A patient-centered approach to the treatment of substance use is helpful in achieving positive treatment outcomes. This study aimed to explore male patients’ preferences for opioid use treatments.
Methods
A qualitative study was conducted in Isfahan, a city in the center of Iran. The study sample included 64 male participants who had started treatment for opioid use disorder (OUD). Using a purposive maximum variation sampling procedure, seven treatment centers were selected as interview venues. The semi-structured face-to-face interviews were conducted in a private room in the selected centers. A hybrid inductive/deductive approach was used to thematize the interview transcripts.
Results
A total of three themes and 13 subthemes on opioid treatment preferences were identified: treatment concerns (anonymity, social stigma, fear of treatment distress, and family concerns), treatment attributes (treatment cost, location of the treatment center, treatment period, frequency of attendance, informed treatment, and treatment personnel), and treatment type (maintenance or abstinence and residential and community treatments). The study showed that all treatment programs were perceived to have their own strengths and weaknesses.
Conclusions
The results showed that patients with OUD carefully compare the positive and negative aspects of existing treatment programs, and they consider a treatment program to be a package of favorable and non-favorable qualities. The identified themes could inform policymakers about the treatment preferences of male patients and provide an opportunity to promote better treatment options for OUD.
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health
Reference53 articles.
1. Merz F. United Nations Office on Drugs and Crime: World Drug Report 2017. 2017. SIRIUS–Zeitschrift für Strategische Analysen. 2018;2(1):85–6.
2. Alam-mehrjerdi Z, Noori R, Dolan K. Opioid use, treatment and harm reduction services: the first report from the Persian Gulf region. J Subst Use. 2016;21(2):217–23.
3. Razzaghi E, et al. Rapid Situation Assessment (RSA) of drug abuse in Iran. Prevention Department, State Welfare Organization, Ministry of Health, IR of Iran and United Nations International Drug Control Program,; 1999.
4. Amin-Esmaeili M, et al. Epidemiology of illicit drug use disorders in Iran: prevalence, correlates, comorbidity and service utilization results from the iranian. Mental Health Survey Addiction. 2016;111(10):1836–47.
5. Alammehrjerdi Z et al. Therapeutic Community Program for opioid-dependent treatment seekers. Iran J Psychiatry Behav Sci, 2017. 11(3).